BNP Paribas Financial Markets’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$464K Sell
26,141
-934
-3% -$14.7K ﹤0.01% 3810
2026
Q1
$388K Sell
27,075
-93,134
-77% -$1.55M ﹤0.01% 3722
2025
Q4
$2.12M Buy
120,209
+43,720
+57% +$723K ﹤0.01% 2587
2025
Q3
$1.2M Buy
76,489
+61,955
+426% +$870K ﹤0.01% 3001
2025
Q2
$162K Sell
14,534
-1,533
-10% -$18K ﹤0.01% 3855
2025
Q1
$187K Buy
16,067
+890
+6% +$11.5K ﹤0.01% 3739
2024
Q4
$208K Buy
+15,177
New +$220K ﹤0.01% 3838
2022
Q4
Sell
-5,479
Closed -$37.4K 4525
2022
Q3
$37.4K Buy
+5,479
New +$91.1K ﹤0.01% 4027

Other funds holding SHC

BNP Paribas Financial Markets's SHC Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Sotera Health (SHC) stake by 3.4% in Q2 2026, selling an estimated $14.7K and leaving 26,141 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #3810.

BNP Paribas Financial Markets first reported a position in SHC in Q3 2022 and has held it in 8 quarters since. The position peaked at $2.12M in Q4 2025. 316 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • BNP Paribas Financial Markets held 26,141 shares of Sotera Health worth $464K as of Q2 2026.
  • BNP Paribas Financial Markets sold 934 Sotera Health shares in Q2 2026, an estimated $14.7K.
  • Sotera Health made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3810 holding.
  • BNP Paribas Financial Markets first reported a position in Sotera Health in Q3 2022 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's Sotera Health position peaked at $2.12M in Q4 2025.
  • 316 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.